Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle ...How to Connect. Whether you have questions about what we do, are looking to partner with us, or are exploring options for clinical trials—please reach out using the form below that best describes the information you need. To contact Verastem Product Information Center Call 1-877-VSTM-ONC. To report an Adverse Event or Product Complaint ...2 days ago · Verastem, Inc. stock has split one time since the company went public. The most recent was a 833333-for-10000000 split on 06/01/2023. View VSTM's stock split history here .Economist Nouriel Roubini said Credit Suisse needs a liquidity lifeline from central banks — and the Swiss National Bank just agreed a $54 billion loan. Jump to Credit Suisse could...Track Vertex Pharmaceuticals, Inc. (VRTX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsLearn more. Track Stem Inc (STEM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors.Chase credit cards with rewards, $0 fees, 0% APRs & more. Compare offers & read Chase credit card reviews. Apply online for the best Chase credit card. WalletHub experts track 1,50...BOSTON, May 31, 2023--Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that it will effect a 1-for-12 ...Verastem (NASDAQ: VSTM) just reported results for the fourth quarter of 2023. Verastem reported earnings per share of -$1.10. This was below the analyst estimate for EPS of -62 cents.Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote …We would like to show you a description here but the site won’t allow us.Investors: Ajay Munshi Vice President, Corporate Development +1 781-469-1579 [email protected] Sherri Spear Argot Partners +1 212-600-1902 [email protected] Media: Lisa Buffington ...10.86. +3.43%. Discover historical prices for VSTM stock on Yahoo Finance. View daily, weekly or monthly format back to when Verastem, Inc. stock was issued.Verastem Oncology. Reconciliation of GAAP to Non-GAAP Financial Information (in thousands, except per share amounts) (unaudited) Three months ended September 30, Nine months ended September 30, 2023 2022 2023 2022. Net loss reconciliation Net loss (GAAP basis) $ (20,004 ) $ (18,090 ) ...Track Microstrategy Inc. (MSTR) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem Oncology is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia. Headquarters: Massachusetts. Founded: 2010. CEO: Brian Stuglik (Jul 2019-)Reparto Universitario Reparto Universitario is a village in Santiago De Los Caballeros (Zona Urbana), Santiago de los Caballeros, Santiago Province.Reparto Universitario is situated close to the neighborhoods La Zurza and La Loteria.TPG readers chimed in to tell us which brands of hotel soaps, shampoos, lotions and conditioners are their favorites. As a rule, the nicer the hotel, the less likely it is that you...May. 25, 2023, 09:05 PM. In a report released yesterday, Mara Goldstein from Mizuho Securities maintained a Hold rating on Verastem ( VSTM - Research Report ), with a price target of $2.00. The ...NEW YORK, Jan. 12, 2024 (GLOBE NEWSWIRE) -- In concert with Cervical Health Awareness Month, PRISM MarketView has added Verastem, Inc., a biopharmaceutical company focused on the development and ...Track Clover Health Investments Corp (CLOV) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival ...Mizuho Securities analyst Mara Goldstein maintained a Hold rating on Verastem (VSTM - Research Report) today and set a price target of $24.00.The company's shares closed yesterday at $1.02 ...Verastem Trading Up 2.5 %. Shares of NASDAQ:VSTM opened at $12.18 on Friday. The business’s 50-day moving average is $11.25 and its 200 day moving …Track ZyVersa Therapeutics Inc (ZVSA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors3 days ago · What is Verastem's stock forecast and purchase recommendation? According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Verastem is $28.79, with a high forecast of $36.00 and a low forecast of $17.50. The consensus rating for Verastem stock is Buy based on the current 6 buy ...Consensus Verastem, Inc. Equities VSTM US92337C2035 Market Closed - Nasdaq. Other stock markets. 04:00:00 2024-05-10 pm EDT 5-day change 1st Jan Change 11.85 USD -0.59% +8.72% +45.58%: May. 09: Verastem, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI ...Track Castor Maritime Inc (CTRM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem Oncology (Nasdaq: VSTM) is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients ...Mar 14, 2024 · BOSTON, March 14, 2024--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today reported financial results for the three ...Verastem (NASDAQ: VSTM) just reported results for the fourth quarter of 2023. Verastem reported earnings per share of -$1.10. This was below the analyst estimate for EPS of -62 cents.BOSTON - Verastem Oncology (Nasdaq: VSTM) (the 'Company'), a biopharmaceutical company committed to advancing new medicines for patients with cancer, announced today results of the efficacy and safety of avutometinib and defactinib in recurrent low-grade serous ovarian cancer (LGSOC) following prior systemic therapy.. The results of this planned subgroup analysis of Part A of the Phase 2 RAMP ...May 16, 2024 · VSTM Competitors. $ Market cap P/E ratio $ Price 1d change 52-week range. View Verastem, Inc. VSTM stock quote prices, financial information, real-time forecasts, and company news from CNN.By Karl Utermohlen, InvestorPlace Writer Dec 15, 2017. DDR (DDR) to spin off 50 properties, Hess (HES) to dethrone John Hess as CEO and Verastem (VSTM) announces $25 million common share offering.AMERICAN FUNDS MULTI-SECTOR INCOME FUND CLASS 529-F-2- Performance charts including intraday, historical charts and prices and keydata. Indices Commodities Currencies Stocks"Bridgerton," the first TV series of Shonda Rhimes' $100 million Netflix deal, is the fifth most-watched show in the history of the streaming service. Netflix is paying TV mega-pro...Verastem Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Verastem Inc's trailing 12-month revenue is $0.0 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. Analysts expect adjusted earnings to reach $-3.974 per share for the current fiscal year.Track VERSES Technologies Inc - Ordinary Shares - Class A (Sub Voting) (VRSSF) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack Sabre Corp (SABR) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors4.1200. -66.17%. NKTR Nektar Therapeutics. 1.6400. -1.20%. Find the latest Geron Corporation (GERN) stock quote, history, news and other vital information to help you with your stock trading and ...The latest Verastem stock prices, stock quotes, news, and VSTM history to help you invest and trade smarter. Menu icon A vertical stack of three evenly spaced horizontal lines.Track JasmyCoin(JASMY) Price, real-time chart movements, latest community messages, chart, news and related information. Share your ideas and get valuable insights from the community of like minded traders and investorsThe transaction, which took place on December 31, 2023, involved the acquisition of 75,537 shares at a trade price of $8.14 per share. This strategic move has expanded Viking Global's holding to a ...Verastem Oncology is currently conducting clinical trials with its RAF/MEK clamp avutometinib in RAS/MAPK driven tumors as part of its (Raf And Mek Program). RAMP 301 (NCT06072781) is a Phase 3 confirmatory trial evaluating the combination of avutometinib and defactinib versus standard chemotherapy or hormonal therapy for the …Verastem stock resides in the small cap universe with a market cap of $263M and a share price of $10.43 which is closing in on its 52-week high share price of $15.12. Over the past year, the stock ...Track Microsoft Corp (MSFT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors2 days ago · Verastem, Inc. is a late-stage development biopharmaceutical company. The Company's pipeline is focused on anticancer agents that inhibit critical signaling pathways in cancer that promote cancer ...Shares of NASDAQ VSTM opened at $12.02 on Monday. The firm's 50-day moving average price is $11.13 and its 200-day moving average price is $9.93. Verastem has a 1-year low of $4.68 and a 1-year ...Track Inspire Veterinary Partners Inc. - Ordinary Shares - Class A (IVP) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsComparatively, 88.4% of Verastem shares are held by institutional investors. 7.7% of Vanda Pharmaceuticals shares are held by company insiders. Comparatively, 2.2% of Verastem shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for ...6 equities research analysts have issued 1 year price objectives for Verastem's shares. Their VSTM share price targets range from $17.50 to $36.00. On average, they expect the company's share price to reach $28.79 in the next year. This suggests a possible upside of 598.7% from the stock's current price.Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival ...Verastem Oncology (Nasdaq: VSTM) is a commercial biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and ...VSTM Competitors. $ Market cap P/E ratio $ Price 1d change 52-week range. View Verastem, Inc. VSTM stock quote prices, financial information, real-time forecasts, and company news from CNN.Andreas Halvorsen's Viking Global Investors LP Bolsters Position in Verastem Inc. The transaction, which took place on December 31, 2023, involved the acquisition of 75,537 shares at a trade price of $8.14 per share. This strategic move has expanded Viking Global's holding to a total of 2,531,829 shares in Verastem Inc, reflecting the firm's ...Track Seres Therapeutics Inc (MCRB) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsFind the latest Viking Therapeutics, Inc. (VKTX) stock quote, history, news and other vital information to help you with your stock trading and investing.BOSTON, March 05, 2024--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients, today announced that the U.S. Food and Drug Administration ...Verastem Oncology (Nasdaq: VSTM) is a late-stage development biopharmaceutical company committed to the development and commercialization of …This press release includes forward-looking statements about Verastem Oncology’s strategy, future plans and prospects, including statements related to the expected outcome and benefits of the collaboration with GenFleet, the potential clinical value of various of its clinical trials, the timing of commencing and completing trials, including ...Track Virios Therapeutics Inc (VIRI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsDetails of the Trade. The acquisition of Verastem Inc shares by Viking Global Investors LP on December 31, 2023, marks a significant addition to the firm's portfolio. The trade, executed at $8.14 ...Source: Verastem, Inc. Verastem Oncology: Brian Sullivan, +1 781-469-1636 Senior Director, Corporate Development [email protected] or Media: FleishmanHillard Adam Silverstein, +1 917-697-9313 [email protected] or Investors: Argot Partners Joseph Rayne, +1 617-340-6075 [email protected]%. BEAT. Home. Symbol. VSTM. Earnings. Checkout Verastem Inc (VSTM) earnings results, EPS expectations and actual EPS values for both quarterly and annual periods. Discover whether VSTM beat the street expectations or not?Verastem Oncology is currently conducting clinical trials with its RAF/MEK clamp avutometinib in RAS pathway-driven tumors as part of its (Raf And Mek Program). RAMP 301 is a Phase 3 confirmatory ...Verastem Oncology. Reconciliation of GAAP to Non-GAAP Financial Information (in thousands, except per share amounts) (unaudited) Three months ended September 30, Nine months ended September 30, 2023 2022 2023 2022. Net loss reconciliation Net loss (GAAP basis) $ (20,004 ) $ (18,090 ) ...Veru is a biopharmaceutical company focused on developing novel medicines for high-quality weight loss, breast cancer, and viral related ARDSBOSTON--(BUSINESS WIRE)--Jun. 22, 2020-- Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to developing and commercializing new medicines for patients battling cancer, today announced results from a study that provides preclinical proof-of-concept for …Track Rumble Inc (RUM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem Oncology Announces Initiation of a Confirmatory Phase 3 Trial of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer. BOSTON-- (BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM) (the “Company”), a biopharmaceutical company committed to advancing new medicines for patients with cancer, announced today that it has ...Track Sunshine Biopharma Inc (SBFM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack Vs Media Holdings Ltd. - Ordinary Shares - Class A (VSME) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem GAAP EPS of -$1.26: May 9: VCEL: Critical Insights From Vericel Analyst Ratings: What You Need To Know: May 9: BLFS: BioLife Solutions GAAP EPS of -$0.22, revenue of $31.7M: May 9: BLFS: BioLife Solutions Reports First Quarter 2024 Financial Results: May 9: VSTM: Verastem Oncology Reports First Quarter 2024 Financial Results and ...Verastem Oncology. Reconciliation of GAAP to Non-GAAP Financial Information (in thousands, except per share amounts) (unaudited) Three months ended September 30, Nine months ended September 30, 2023 2022 2023 2022. Net loss reconciliation Net loss (GAAP basis) $ (20,004 ) $ (18,090 ) ...Track Vertex Energy Inc (VTNR) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsRegistration-Directed RAMP-201 Trial Designed to Address High Unmet Need in Low-Grade Serous Ovarian Cancer, a Unique and Distinct Type of Ovarian Cancer with Limited Treatment Options . BOSTON--(BUSINESS WIRE)--Apr. 26, 2023-- Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines …Discover Verastem Inc (VSTM) market and community sentiment, movement in message volume, participation score and buzz level in the Stocktwits communityShares of Verastem, Inc. (NASDAQ:VSTM - Get Free Report) have been assigned an average recommendation of "Buy" from the six brokerages that are covering the firm, Marketbeat.com reports.Six investment analysts have rated the stock with a buy recommendation. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $28.79.Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed ...Find the latest Curis, Inc. (CRIS) stock quote, history, news and other vital information to help you with your stock trading and investing.We would like to show you a description here but the site won’t allow us.Share on Twitter Share on Facebook Share on LinkedIn Share on Stocktwits. Brightcove Inc. (NASDAQ:BCOV – Get Free Report)’s stock price passed above its two …Verastem will be responsible for future development of CH5126766 and its commercialization globally. The company may look for various partnering strategies for development of the candidate.